Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, Morepen Laboratories has informed about the launch of four new products, namely Ticapen, UdoFix, LycoMore, and Acifix by the Company. The necessary information regarding the aforesaid product launch, including disclosures as required under the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given in the ‘Annexure’ titled ‘Morepen Doubles Down on Rx Innovation’.
The above information is a part of company’s filings submitted to BSE.
